JNS Open Access Articles

2020

Review Articles

Richards D, Morren JA, Pioro EP. Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 2020 Oct 15;417:117054.

Li X, Du H, Song Z, Wang H, Tan Z, Xiao M, Zhang F. Efficacy and safety of sonothrombolysis in patients with acute ischemic stroke: a systematic review and meta-analysis. Journal of the Neurological Sciences. 2020 Sep 15;416:116998.

Frohman EM, Villemarette-Pittman NR, Melamed E, Cruz RA, Longmuir R, Varkey TC, Steinman L, Zamvil SS, Frohman TC. Part I. SARS-CoV-2 triggered ‘PANIC’attack in severe COVID-19. Journal of the neurological sciences. 2020 Aug 15;415:116936.

Frohman EM, Villemarette-Pittman NR, Cruz RA, Longmuir R, Rowe V, Rowe ES, Varkey TC, Steinman L, Zamvil SS, Frohman TC. Part II. High-dose methotrexate with leucovorin rescue for severe COVID-19: an immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’attack. Journal of the neurological sciences. 2020 Aug 15;415:116935.

Román GC, Spencer PS, Reis J, Buguet A, Faris ME, Katrak SM, Lainez M, Medina MT, Meshram C, Mizusawa H, Öztürk S. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. Journal of the neurological sciences. 2020 Jul 15;414:116884.

Stanak M, Wolf S, Jagoš H, Zebenholzer K. The impact of external trigeminal nerve stimulator (e-TNS) on prevention and acute treatment of episodic and chronic migraine: a systematic review. Journal of the Neurological Sciences. 2020 May 15;412:116725.

Basic Research Papers

Kurihara K, Nakagawa R, Ishido M, Yoshinaga Y, Watanabe J, Hayashi Y, Mishima T, Fujioka S, Tsuboi Y. Impact of motor and nonmotor symptoms in Parkinson disease for the quality of life: The Japanese Quality-of-Life Survey of Parkinson Disease (JAQPAD) study. Journal of the Neurological Sciences. 2020 Dec 15;419:117172.

Ouyang M, Zhang Y, Wang X, Song L, Billot L, Robinson T, Lavados PM, Arima H, Hackett ML, Olavarría VV, Munoz-Venturelli P. Quantifying regional variations in components of acute stroke unit (ASU) care in the international HeadPoST study. Journal of the Neurological Sciences. 2020 Dec 15;419:117187.

Kitano T, Sakaguchi M, Yamagami H, Ishikawa T, Ishibashi-Ueda H, Tanaka K, Okazaki S, Sasaki T, Kadono Y, Takagaki M, Nishida T. Mechanical thrombectomy in acute ischemic stroke patients with left ventricular assist device. Journal of the Neurological Sciences. 2020 Nov 15;418:117142.

Chipika RH, Christidi F, Finegan E, Shing SL, McKenna MC, Chang KM, Karavasilis E, Doherty MA, Hengeveld JC, Vajda A, Pender N. Amygdala pathology in amyotrophic lateral sclerosis and primary lateral sclerosis. Journal of the Neurological Sciences. 2020 Oct 15;417:117039.

Weller D, Lörincz L, Sutter T, Reuter K, Linnebank M, Weller M, Zörner B, Filli L. Fampridine-induced changes in walking kinetics are associated with clinical improvements in patients with multiple sclerosis. Journal of the neurological sciences. 2020 Sep 15;416:116978.

Wang S, Lin L, Wang Y, Wang A, Liu Z, Wu S, Lan X, Jia J, Zhang Y, Yuan F, Wang C. Novel homozygous mutation in the FBXL4 gene is associated with mitochondria DNA depletion syndrome-13. Journal of the Neurological Sciences. 2020 Sep 15;416:116948.

Patel N, Banahan C, Janus J, Horsfield MA, Cox A, Marshall D, Colman J, Morlese J, Evans DH, Hannon C, Egan V. Neurological impact of emboli during adult cardiac surgery. Journal of the neurological sciences. 2020 Sep 15;416:117006.

Colosimo C, Charles D, Misra VP, Maisonobe P, Om S, INTEREST IN CD2 study group. Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: findings from a prospective, observational study. Journal of the Neurological Sciences. 2020 Sep 15;416:117015.

Koopman I, Zuithoff NP, Rinkel GJ, Vergouwen MD. The course of cerebrospinal fluid parameters≤ 20 days after aneurysmal subarachnoid hemorrhage. Journal of the Neurological Sciences. 2020 Aug 15;415:116899.

Azad B, Efthymiou S, Sultan T, Scala M, Alvi JR, Neuray C, Dominik N, Gul A, Houlden H, SYNaPS Study Group. Novel likely disease-causing CLN5 variants identified in Pakistani patients with neuronal ceroid lipofuscinosis. Journal of the Neurological Sciences. 2020 Jul 15;414:116826.

Biesbroek JM, Lam BY, Zhao L, Tang Y, Wang Z, Abrigo J, Chu WW, Wong A, Shi L, Kuijf HJ, Biessels GJ. High white matter hyperintensity burden in strategic white matter tracts relates to worse global cognitive performance in community-dwelling individuals. Journal of the Neurological Sciences. 2020 Jul 15;414:116835.

Le-Rademacher JG, Lopez CL, Kanwar R, Major-Elechi B, Abyzov A, Banck MS, Therneau TM, Sloan JA, Loprinzi CL, Beutler AS. Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes. Journal of the neurological sciences. 2020 Apr 15;411:116687.

Ishii N, Mochizuki Y, Shiomi K, Nakazato M, Mochizuki H. Spiral drawing: Quantitative analysis and artificial-intelligence-based diagnosis using a smartphone. Journal of the neurological sciences. 2020 Apr 15;411:116723.

Gjerum L, Frederiksen KS, Henriksen OM, Law I, Anderberg L, Andersen BB, Bjerregaard E, Hejl AM, Høgh P, Hasselbalch SG. A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease. Journal of the Neurological Sciences. 2020 Mar 15;410:116645.

Akiba C, Gyanwali B, Villaraza S, Nakajima M, Miyajima M, Cheng CY, Wong TY, Venketasubramanian N, Hilal S, Chen C. The prevalence and clinical associations of disproportionately enlarged subarachnoid space hydrocephalus (DESH), an imaging feature of idiopathic normal pressure hydrocephalus in community and memory clinic based Singaporean cohorts. Journal of the Neurological Sciences. 2020 Jan 15;408:116510.

Allen JA, Gelinas DF, Freimer M, Runken MC, Wolfe GI. Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?. Journal of the Neurological Sciences. 2020 Jan 15;408:116497.

Clinical Short Communications

Bringeland GH, Myhr KM, Vedeler CA, Gavasso S. Wearing-off at the end of natalizumab dosing interval and risk of MS disease activity: A prospective 1-year follow-up study. Journal of the Neurological Sciences. 2020 Aug 15;415:116880.